Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 3508 TB, 3508, TB, Utrecht, The Netherlands.
ChemMedChem. 2017 Apr 6;12(7):483-486. doi: 10.1002/cmdc.201700050. Epub 2017 Mar 22.
A series of lipidated guanidino and urea derivatives of 1,5-dideoxy-1,5-imino-d-xylitol were prepared from d-xylose using a concise synthetic protocol. Inhibition assays with a panel of glycosidases revealed that the guanidino analogues display potent inhibition against human recombinant β-glucocerebrosidase with IC values in the low nanomolar range. Related urea analogues of 1,5-dideoxy-1,5-imino-d-xylitol were also synthesized and evaluated in the same fashion and found to be selective for β-galactosidase from bovine liver. No inhibition of human recombinant β-glucocerebrosidase was observed for the urea analogues. Computational studies provided insight into the potent activity of analogues bearing the substituted guanidine moiety in the inhibition of lysosomal glucocerebrosidase (GBA).
一系列 1,5-二脱氧-1,5-亚氨基-D-木酮糖的胍基和脲基衍生物是由 D-木糖通过简洁的合成方案制备的。用糖苷酶进行的抑制试验表明,胍类似物对人重组β-葡糖脑苷脂酶具有很强的抑制作用,IC 值在低纳摩尔范围内。以同样的方式合成并评价了 1,5-二脱氧-1,5-亚氨基-D-木酮糖的相关脲类似物,发现它们对牛肝来源的β-半乳糖苷酶具有选择性。脲类似物对人重组β-葡糖脑苷脂酶没有抑制作用。计算研究深入了解了在抑制溶酶体葡糖脑苷脂酶(GBA)中具有取代胍部分的类似物的强活性。